Optimizing collimator margins for isotoxically dose-escalated conformal radiation therapy of non-small cell lung cancer.

Optimizing collimator margins for isotoxically dose-escalated conformal radiation therapy of non-small cell lung cancer.

PURPOSE: Isotoxic dose escalation schedules such as IDEAL-CRT [isotoxic dose escalation and acceleration in lung cancer chemoradiation therapy] (ISRCTN12155469) individualize doses prescribed to lung tumors, generating a fixed modeled risk of radiation pneumonitis. Because the beam penumbra is broad...

Full description

Bibliographic Details
Main Authors:	Warren, S, Panettieri, V, Panakis, N, Bates, N, Lester, J, Jain, P, Landau, D, Nahum, A, Mayles, W, Fenwick, J
Format:	Journal article
Language:	English
Published:	Elsevier 2014

Similar Items

Influence of dose calculation algorithms on isotoxic dose-escalation of non-small cell lung cancer radiotherapy.
by: Panettieri, V, et al.
Published: (2010)

Clinical and dosimetric factors impacting radiation pneumonitis in isotoxically dose-escalated NSCLC
by: Vivekanandan, S, et al.
Published: (2017)

Isotoxic dose escalation with real-time imaging on an MR-linac in lung radiation therapy
by: Bendall, L, et al.
Published: (2018)

Normal tissue doses during isotoxically dose escalated lung radiation therapy using MR-linacs
by: Bendall, L, et al.
Published: (2018)

The I-START trial: ISoToxic Accelerated RadioTherapy in locally advanced non-small cell lung cancer
by: Lester, J, et al.
Published: (2012)

Dose Escalation for Pancreas SBRT: Potential and Limitations of using Daily Online Adaptive Radiation Therapy and an Iterative Isotoxicity Automated Planning Approach
by: Dong Joo Rhee, PhD, et al.
Published: (2023-07-01)

A phase I/II trial of concurrent chemo-radiation with dose-escalated radiotherapy in patients with stage II or stage III non-small cell lung cancer
by: Landau, D, et al.
Published: (2013)

Dosimetric feasibility analysis and presentation of an isotoxic dose-escalated radiation therapy concept for glioblastoma used in the PRIDE trial (NOA-28; ARO-2022-12)
by: Raphael Bodensohn, et al.
Published: (2024-03-01)

Early mucosal reactions during and after head-and-neck radiotherapy: dependence of treatment tolerance on radiation dose and schedule duration.
by: Fenwick, J, et al.
Published: (2008)

Escalation and intensification of radiotherapy for stage III non-small cell lung cancer: opportunities for treatment improvement.
by: Fenwick, J, et al.
Published: (2009)

UK proposal for three parallel dose escalation studies in radiotherapy (RT) for Stage I-III non-small cell lung cancer (NSCLQC)-DEAL-RT
by: Hughes, S, et al.
Published: (2007)

Improvement in tumour control probability with active breathing control and dose escalation: a modelling study.
by: Partridge, M, et al.
Published: (2009)

Investigation of Isotoxic Dose Escalation and Plan Quality with TDABC Analysis on a 0.35 T MR-Linac (MRL) System in Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided Radiation Therapy (MRgRT) for Primary Pancreatic Cancer
by: Robert Hawranko, et al.
Published: (2022-05-01)

Safety and tumour hypoxia modifying effect of buparlisib with radiotherapy in NSCLC: a phase I dose escalation study
by: Skwarski, M, et al.
Published: (2018)

Isotoxic high-dose stereotactic body radiotherapy integrated in a total multimodal neoadjuvant strategy for the treatment of localized pancreatic ductal adenocarcinoma
by: Christelle Bouchart, et al.
Published: (2021-10-01)

Radiation treatment planning with embedded dose escalation
by: William T. Hrinivich, et al.
Published: (2019-08-01)

Proton versus photon therapy for high-risk prostate cancer with dose escalation of dominant intraprostatic lesions: a preliminary planning study
by: Ashley Li Kuan Ong, et al.
Published: (2023-11-01)

Analysis of tumour control probability, normal tissue complication probability and isotoxic effects for prostate cancer
by: Fauzee, Nurnada Syahrain Mohd
Published: (2016)

Marginal deterrence: The effect of illicit incentive on robbery escalation
by: Christopher E. Torres, et al.
Published: (2024-06-01)

Correlations between dose-surface histograms and the incidence of long-term rectal bleeding following conformal or conventional radiotherapy treatment of prostate cancer.
by: Fenwick, J, et al.
Published: (2001)

Proper collimation effect on radiation dose and image quality in thoracic spine radiography
by: Pazanin Anamaria, et al.
Published: (2020-01-01)

Isotoxic High-Dose Stereotactic Body Radiotherapy (iHD-SBRT) Versus Conventional Chemoradiotherapy for Localized Pancreatic Cancer: A Single Cancer Center Evaluation
by: Martin Manderlier, et al.
Published: (2022-11-01)

Impact of dose-distribution uncertainties on rectal ntcp modeling. I: Uncertainty estimates.
by: Fenwick, J, et al.
Published: (2001)

Personalized dose escalation in anal cancer
by: Robinson, M, et al.
Published: (2016)

Comparison Between Dose-Escalated Intensity Modulated Radiation Therapy and 3-Dimensional Conformal Radiation Therapy for Salvage Radiation Therapy After Prostatectomy
by: Nana Shimoyachi, MD, et al.
Published: (2021-11-01)

The role of biological dose-escalation for pancreatic cancer
by: Anna M.E. Bruynzeel, et al.
Published: (2019-09-01)

The ARCS radial collimator
by: Stone M.B., et al.
Published: (2015-01-01)

Geometric leaf placement strategies.
by: Fenwick, J, et al.
Published: (2004)

Dose escalation of a curcuminoid formulation
by: Crowell James, et al.
Published: (2006-03-01)

Experimental Measurement and Analysis: Collimation and Illumination for Conformity Measuring Instrument Design in X-ray Modality
by: Fathul Fajar, et al.
Published: (2023-05-01)

Treatment planning of dose escalation for anal cancer in the PLATO trial
by: Abbott, N, et al.
Published: (2017)

Wakefields in SLAC linac collimators
by: A. Novokhatski, et al.
Published: (2014-12-01)

Wire mesh collimator
by: Saripan, M. Iqbal, et al.
Published: (2008)

GRIN collimating lenses
by: Mohd. Supa'at, Abu Sahmah, et al.
Published: (2007)

Dose escalation of 5ASA: does it work?
by: Travis, S
Published: (2005)

Dose-escalating ruxolitinib for refractory hemophagocytic lymphohistiocytosis
by: Yue Song, et al.
Published: (2023-06-01)

The effect of dose escalation on gastric toxicity when treating lower oesophageal tumours: a radiobiological investigation
by: Warren, S, et al.
Published: (2015)

Radiation dose escalation for loco-regional recurrence of breast cancer after mastectomy
by: Skinner Heath D, et al.
Published: (2013-01-01)

Enhancing the clinical activity of sorafenib through dose escalation: rationale and current experience
by: Thomas J. Semrad, et al.
Published: (2011-03-01)

Improved Outcomes With Dose Escalated Hypofractionated Radiotherapy for Prostate Cancer
by: Mackenzie, J, et al.
Published: (2011)